ThinkEquity Downgrades Pharmasset (VRUS) to Hold

January 7, 2011 8:22 AM UTC Send to a Friend
ThinkEquity downgraded Pharmasset (NASDAQ: VRUS) to Hold. PT $45.
This article: 45 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login